Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Results showed that 26.41% of patients died, with mortality analysis revealing a hazard ratio of 3.2 for patients with vitamin D levels below 15 ng/mL.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Multiple reported designs.

Multiple reported designs

More than one design is explicitly reported; examine the supporting methods.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Association Between Serum Vitamin D Levels and Mortality in Children Receiving Chronic Dialysis: A Retrospective Cohort Study

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Association Between Serum Vitamin D Levels and Mortality in Children Receiving Chronic Dialysis: A Retrospective Cohort Study

Multiple reported designs · Health Science Reports · 2026

Original publication title

Association Between Serum Vitamin D Levels and Mortality in Children Receiving Chronic Dialysis: A Retrospective Cohort Study

Sima Shamshiri Khamene; Izat Mohammad Khawajah; Mastaneh Moghtaderi

© 2026 The Author(s). Health Science Reports published by Wiley Periodicals LLC.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In conclusion, children with end‐stage renal disease undergoing dialysis face increased risks of vitamin D deficiency due to impaired kidney function. This deficiency significantly impacts survival rates and contributes to poor outcomes. Regular monitoring and management of vitamin D levels are crucial for improving survival in pediatric dialysis patients.

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

Vitamin D has multifunctional and also hormone‐like functions [1]. Most of the vitamin D in the body is produced in the skin (80%: 90%) through exposure to UVB, and a small amount is derived from foods (10%: 20%) [2]. Its hydroxylated form turns into 25‐hydroxy vitamin D(25‐OHD) in the liver, and the next hydroxylation takes part in the kidneys, turning it into active 1‐25hydroxy vitamin D (1‐25OH2D) [3, 4, 5]. Therefore, the main factors affecting serum vitamin D levels are sunlight, diet, age, gender, and weight.

Main dietary sources of vitamin D are enriched milks, fish, and oral supplements. Skeletal hemostasis, reproductive system function especially in females, cardiovascular system, and calcium and phosphorus hemostasis depend on normal serum vitamin D (more than 30 ng/mL) [5, 6, 7, 8, 9, 10]. Decreased serum vitamin D may have some part in disorders such as depression, cancer, fractures, and impaired immune system function [10, 11]. Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) are the main regulators of vitamin D.

Vitamin D deficiency is quite common in children with chronic kidney disease (CKD). It is one of the most common comorbidities in CKD patients, such as reduced glomerular filtration rate (GFR), proteinuria, and other diseases like diabetes [12, 13, 14, 15]. Impaired renal function is directly associated with secondary hyperparathyroidism [13], and the greater the GFR decrease, the greater the serum PTH level [5]. Advanced stages of CKD (stage 4 to 5) show more severe vitamin D deficiency compared to the moderate stages [3].

There is an elevated level of inflammatory factors and C Reactive Protein (CRP) in CKD patients and some evidence showed supplements can reduce these indices efficiently [15, 16]. Children on chronic dialysis programs probably have lower vitamin D levels because of impaired nutrition and dialysis itself [16, 17]. Lack of vitamin D causes hyperphosphatemia and hypocalcemia, resulting in increased PTH level and secondary hyperparathyroidism [18, 19]. FGF23 reduces PTH level in the early phase, but eventually both of them end up in the rise of it by some mechanisms [1, 20].

CKD children have a greater risk for vitamin D deficiency because they lack enough activity and don’t get enough sunlight, and also, uremia itself reduces vitamin D synthesis. Therefore, supplements in the form of active vitamin D3 are suggested to be used in CKD stage 2 to 5 to prevent secondary hyperparathyroidism and its consequences [21]. Overall, up to 90% of patients who are routinely on dialysis programs are vitamin D deficient, which is associated with increased arterial stiffness and calcification of vasculature, stroke, and left ventricular hypertrophy, and also increased mortality due to cardiovascular accidents [1, 12].

The purpose of this study was to review and assess children on regular dialysis programs and evaluate their serum vitamin D level and its relationship with calcium, phosphorus, serum PTH, and mortality in these patients.

Source: Introduction

Study methods

What methods does the paper describe?

The study was designed as a retrospective observational cross‐sectional study, and no new intervention was performed. All data from this study were collected retrospectively. All patients undergoing regular hemodialysis and peritoneal dialysis from 2018 to 2020 (53 patients) enrolled in the study. Patients with underlying non‐renal diseases such as hypertension, adrenal hyperplasia, coarctation of the aorta, and pheochromocytoma were excluded from the study. The variable of interest was age, gender, body mass index (BMI), drugs, type of dialysis, hypertension, calcium (Ca), phosphorus(P), and vitamin D level, PTH and CRP and urine residue, as well as diet compliance were evaluated every 1 to 3 months.

Arterial hypertension is defined by a sustained rise of blood pressure in 95% of recorded charts of BP. The χ 2 test was used to analyze the categorical variables. Statistical inferences related to associations between the serum 25(OH)D level and the outcomes were analyzed using the multivariate Cox proportional hazards regression analyses. p values more than 0.05 were considered statistically insignificant. All statistical analyses were done using statistical package for the social sciences (SPSS) Statistics 21 and analyzed to find any meaningful relations.

Source: Materials and Methods

Discussion

In this study of 53 pediatric dialysis patients, our most significant finding was the strong association between vitamin D levels and mortality, with patients having vitamin D levels below 15 ng/mL showing a hazard ratio of 3.2. This relationship was clearly demonstrated in mortality rates, where patients with severe vitamin D deficiency (< 15 ng/mL) experienced a 64.7% mortality rate, those with moderate deficiency (15 to 30 ng/mL) showed an 18.8% mortality rate, while remarkably, patients with sufficient vitamin D levels (> 30 ng/mL) recorded no deaths.

Our analyses also revealed significant positive correlations between vitamin D levels and both calcium levels and duration of dialysis, though no significant correlations were found with other clinical parameters.

Solarin and his colleagues conducted a retrospective investigation in 2019 that focused on the vitamin D status of children with moderate to severe chronic kidney disease. The research involved 46 children and adolescents below the age of 18, including 22 girls and 24 boys [16]. The findings indicated that while low vitamin D levels were linked to older age, there was no significant inverse correlation between vitamin D and PTH. In our study also, no significant association was observed between vitamin D and the age of children.

The Solarin study revealed that there was no correlation between gender and vitamin D levels, and those undergoing peritoneal dialysis exhibited lower vitamin D levels. Our study had similar results. In our study mortality rate had a significant relationship with peritoneal dialysis patients and low serum level of vitamin D. In a cross‐sectional study published in 2017 by Paulo Coccia and his colleagues, they studied 32 healthy control and 135 cases of CKD children and adolescents under 19 years old, they found Vitamin D deficiency is prevalent in 12.5% of controls and 25% of patients.

Patients with vitamin D deficiency had higher PTH levels and phosphate levels [22]. In our study, univariate analyses showed vitamin D level is directly associated with calcium and phosphorus (p > 0.05), but there was no significant association with age, sex, weight, underlying disease, urinary residue, and the number of dialyses per week (p < 0.05). In a case‐control study published by Doaa M. Youssef and her colleagues on 27 ESRD cases and 20 controls in 2010, they found no significant relationship between age, disease duration, dialysis duration, and PTH between the subgroups of ESRD [23].

Similar to our findings, where calcitriol supplementation in dialysis patients showed no significant effect on mortality and spinal fracture rates, only one study has demonstrated improved survival rates with calcitriol treatment in hemodialysis patients [17]. Another cross‐sectional study by Debora R. Stein and her colleagues on 100 CKD patients, including 60 boys and 40 girls in 2012 found a high prevalence of hyperparathyroidism in the early stages of disease and a significant relationship between vitamin D and PTH.

Also, this study showed that improving vitamin D levels is effective in controlling of hyperparathyroidism [24]. Unlike our study, no significant relationship between vitamin D and PTH was observed. Based on Spearman’s correlation analysis there was a weak relationship between calcium and years of dialysis with vitamin D (p < 0.05). In cross‐sectional study done by H. Taskapan and his colleagues in 2006, on 273 children undergoing peritoneal dialysis (123 girls and 150 boys) they did not find any significant relation between the level of 25(OH)D3 and the gender of the patients [25].

Also, they report an inverse correlation between the level of 25(OH)D3, age and the presence of diabetes, and a direct correlation of calcium and 1,25(OH)2D3 was reported. In our study, we find a significant correlation between serum vitamin D and calcium, but there is no significant relation with the gender of the patients. Maryanne Machado da Silva Canhos and colleagues showed annual average vitamin D levels < 23.1 ng/mL were associated with higher all‐cause mortality [26]. Regardless of the confounding variables evaluated, in our study serum vitamin D less than 15 ng/ml was associated with higher mortality rate although some studies suggest serum level of 25(OH)D below 23.6 ng/mL in summer is associated with higher mortality rates [26].

Source: Discussion Source: Discussion

Implication for Practice

According to our study, managing vitamin D supplementation in children on dialysis can follow standard WHO (KDIGO) guidelines, similar to the approach used for healthy children, regardless of their serum vitamin D levels. We observed that children with CKD who maintain residual kidney function typically demonstrate more favorable vitamin D levels, which can be attributed to their remaining functional renal tissue continuing to participate in vitamin D metabolism. For optimal care of children on regular dialysis programs, consistent monitoring of vitamin D, calcium, phosphorus, and PTH levels is essential.

This vigilant monitoring approach plays a crucial role in preventing renal osteodystrophy, reducing the risk of bone fractures, avoiding cardiovascular complications, and ultimately lowering both morbidity and mortality rates in this vulnerable population.

Source: Implication for Practice

Transparency Statement

The corresponding author, Mastaneh Moghtaderi, affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.

Source: Transparency Statement

Results

This comprehensive study analyzed 53 pediatric dialysis patients, consisting of 28 boys and 25 girls. The demographic distribution revealed an average age of 8.21 months with a median of 9 years. The age categories were distinctly represented, with adolescents (over 12 years) comprising 8.2% of the population, children between 2 and 12 years representing the majority at 71.7%, and infants under 2 years accounting for 7.5% of the study population.

The assessment of residual kidney function revealed important distinctions among the patients. Thirty patients (56.7%) demonstrated no residual kidney function, while 23 patients (43.3%) maintained varying degrees of residual function. The metabolic status of the patients showed significant variations, with 32 patients (60%) presenting with metabolic acidosis, a single patient (1.8%) exhibiting metabolic alkalosis, and 20 patients (38.2%) maintaining normal acid‐base balance.

Laboratory analyses yielded crucial insights into vitamin D metabolism and related parameters. The mean serum vitamin D level was 23.51 ng/mL (median 22), displaying a positively skewed distribution that suggested a tendency toward deficiency in the study population. Parathyroid hormone levels demonstrated considerable variation, with a mean PTH level of 411.57, a median of 290, and a mode of 110, indicating diverse patterns of secondary hyperparathyroidism among the patients.

Statistical analyses revealed significant relationships between various parameters. Vitamin D levels showed a moderate positive correlation with calcium levels (correlation coefficient 0.6, p < 0.05) and duration of dialysis (correlation coefficient 0.52, p < 0.05). Through linear regression analysis, it was determined that vitamin D levels explained 12% of calcium variations (adjusted R² = 0.12). The duration of dialysis demonstrated a weak but significant correlation with calcium levels (correlation coefficient 0.2), with dialysis duration explaining 5% of serum calcium variations.

The mortality analysis revealed particularly striking findings. During the study period, 14 deaths were recorded, with statistical analysis demonstrating a highly significant association between vitamin D levels and mortality (p < 0.001). Patients with vitamin D levels below 15 ng/mL faced a hazard ratio of 3.2, indicating more than three times the mortality risk compared to those with higher vitamin D levels. The mortality pattern demonstrated clear stratification based on vitamin D levels, with severely deficient patients (< 15 ng/mL) experiencing a 64.7% mortality rate, moderately deficient patients (15 to 30 ng/mL) showing an 18.8% mortality rate, while remarkably, patients maintaining sufficient vitamin D levels (> 30 ng/mL) recorded no deaths during the study period (Figure 1).

The 24‐month survival analysis further reinforced these findings, demonstrating a clear gradient in survival rates. Patients with sufficient vitamin D levels maintained 100% survival, while those with severe deficiency showed only 35.3% survival. Notably, vitamin D levels below 15 ng/mL during summer months were particularly associated with increased mortality risk, establishing this threshold as a critical marker for clinical assessment.

Figure 1

Distribution of mortality by vitamin D level.

Figure image at the original source: open the original paper. This file is not included in this text import.

Comparative analysis between survivors and non‐survivors revealed no significant differences in several clinical parameters, including sex, dialysis frequency, weight, BMI, and CRP levels, suggesting that these factors may not be primary determinants of mortality in this population. Additionally, no significant correlations were identified between vitamin D levels and phosphorus, PTH, dialysis frequency, age, or weight (p > 0.05), suggesting independent regulatory mechanisms for these parameters.

The relationship between vitamin D levels and mortality remained robust and significant even after adjusting for potential confounding factors, establishing vitamin D status as an independent predictor of mortality risk. The identification of 15 ng/mL as a critical threshold for increased mortality risk provides an important clinical benchmark for risk assessment and intervention. These findings strongly suggest that vitamin D levels serve as a reliable prognostic indicator in pediatric dialysis patients, offering valuable guidance for clinical management and therapeutic intervention strategies.

Figure 1 shows the distribution of mortality by vitamin D levels. Table 1 demonstrates the demographic features in the study population, Table 2 shows the qualitative variables in the study population, and Table 3 presents the correlation of independent variables with vitamin D in dialysis in our patients.

Table 1

Demographic features in the study population.

Age (year)Weight (kg)Vitamin D (ng/mL)CaPPTHNumber of dialysis/weakYears on dialysis
Mean8.2126.6433.518.986.18411.572.743.17
Median926339629032
Mode5122294.3011031
Std. deviation4.31617.00918.4211.051.81354.370.442.73
Variance18.62289.31339.331.113.30125583.280.197.46
Range1473804.206.801403110
Minimum1446.803.302721
Maximum1577841110.101430311
Percentile
25512208.44.5128.521
50926339629032
75123643.59.87.4581.534

Abbreviations: Ca, Calcium; Ph, phosphorus; PTH, parathyroid hormone, if multiple modes exist then the smallest value is shown for mode.

John Wiley & Sons, Ltd.
Table 2

Qualitative variables in the study population.

FrequencyPercentValid percentCumulative percent
PUV + neurogenic bladder1630.230.230.2
Renal dysplasia815.115.145.3
RPGN/FSGS815.115.160.4
CHD, ARPKD, interstitial nephritis2139.639.6100
Renal residueYes2139.639.639.6
No3260.460.4100
Hemodialysis3056.656.656.6
Peritoneal dialysis2343.443.4100

Abbreviations: CHD, congenital heart disease; FSGS, focal segmental glomerulosclerosis; PUV, posterior urethral valves, RPGN, rapidly progressive glomerulonephritis.

John Wiley & Sons, Ltd.
Table 3

Correlation of independent variables with vitamin D in dialysis patients.

HTNMeanStd. deviation p value
HemoglobinYes10.99771.026270.05
No12.17501.76048
PTHYes164.10087.66540.991
No165.250139.2465
Vitamin DYes23.5168.52800.808
No41.33312.5628
Time of hemodialysis per dayYes2.8530.55240.155
No2.5880.5073
Number of dialysis per weekYes2.9410.55570.259
No3.1760.6359
John Wiley & Sons, Ltd.
Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results

Abstract: Conclusion

In conclusion, children with end‐stage renal disease undergoing dialysis face increased risks of vitamin D deficiency due to impaired kidney function. This deficiency significantly impacts survival rates and contributes to poor outcomes. Regular monitoring and management of vitamin D levels are crucial for improving survival in pediatric dialysis patients.

Source: Conclusion
Authors’ abstract

ABSTRACT

Background

Vitamin D deficiency is highly prevalent among children on regular dialysis, affecting approximately 90% of patients. This deficiency (serum 25‐hydroxyvitamin D < 50 nmol/L or 20 ng/mL) is associated with various complications, including skeletal problems, increased infection risk, arterial stiffness, vascular calcification, and higher cardiovascular mortality. Severe deficiency (< 30 nmol/L) particularly increases mortality risks.

Method

In this cross‐sectional retrospective study, we examined 53 pediatric patients (28 boys, 25 girls) undergoing regular dialysis (hemodialysis and peritoneal dialysis) at a children’s medical center from 2018 to 2020. The mean age was 8.21 years, with 71.7% aged 2 to 12 years, 20.8% adolescents, and 7.5% under 2 years. The mean vitamin D level was 23.51 ng/mL.

Results

Results showed that 26.41% of patients died, with mortality analysis revealing a hazard ratio of 3.2 for patients with vitamin D levels below 15 ng/mL. The mortality rate was 64.7% in severe deficiency (< 15 ng/mL), 18.8% in moderate deficiency (15 to 30 ng/mL), while patients with sufficient levels (> 30 ng/mL) recorded no deaths. Additionally, 11.32% developed skeletal disorders, including two cases of spinal fracture. Vitamin D levels showed significant positive correlations with calcium (r = 0.6) and years under dialysis (r = 0.52) (p > 0.05).

Associations were found between vitamin D levels and phosphorus, PTH, and mortality rates. However, no significant relationships were observed with dialysis frequency, age, weight, gender, underlying disease, dialysis type, or hypertension.

Conclusion

In conclusion, children with end‐stage renal disease undergoing dialysis face increased risks of vitamin D deficiency due to impaired kidney function. This deficiency significantly impacts survival rates and contributes to poor outcomes. Regular monitoring and management of vitamin D levels are crucial for improving survival in pediatric dialysis patients.

Read the full paper
1

Introduction

Vitamin D has multifunctional and also hormone‐like functions [1]. Most of the vitamin D in the body is produced in the skin (80%: 90%) through exposure to UVB, and a small amount is derived from foods (10%: 20%) [2]. Its hydroxylated form turns into 25‐hydroxy vitamin D(25‐OHD) in the liver, and the next hydroxylation takes part in the kidneys, turning it into active 1‐25hydroxy vitamin D (1‐25OH2D) [3, 4, 5]. Therefore, the main factors affecting serum vitamin D levels are sunlight, diet, age, gender, and weight.

Main dietary sources of vitamin D are enriched milks, fish, and oral supplements. Skeletal hemostasis, reproductive system function especially in females, cardiovascular system, and calcium and phosphorus hemostasis depend on normal serum vitamin D (more than 30 ng/mL) [5, 6, 7, 8, 9, 10]. Decreased serum vitamin D may have some part in disorders such as depression, cancer, fractures, and impaired immune system function [10, 11]. Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) are the main regulators of vitamin D.

Vitamin D deficiency is quite common in children with chronic kidney disease (CKD). It is one of the most common comorbidities in CKD patients, such as reduced glomerular filtration rate (GFR), proteinuria, and other diseases like diabetes [12, 13, 14, 15]. Impaired renal function is directly associated with secondary hyperparathyroidism [13], and the greater the GFR decrease, the greater the serum PTH level [5]. Advanced stages of CKD (stage 4 to 5) show more severe vitamin D deficiency compared to the moderate stages [3].

There is an elevated level of inflammatory factors and C Reactive Protein (CRP) in CKD patients and some evidence showed supplements can reduce these indices efficiently [15, 16]. Children on chronic dialysis programs probably have lower vitamin D levels because of impaired nutrition and dialysis itself [16, 17]. Lack of vitamin D causes hyperphosphatemia and hypocalcemia, resulting in increased PTH level and secondary hyperparathyroidism [18, 19]. FGF23 reduces PTH level in the early phase, but eventually both of them end up in the rise of it by some mechanisms [1, 20].

CKD children have a greater risk for vitamin D deficiency because they lack enough activity and don’t get enough sunlight, and also, uremia itself reduces vitamin D synthesis. Therefore, supplements in the form of active vitamin D3 are suggested to be used in CKD stage 2 to 5 to prevent secondary hyperparathyroidism and its consequences [21]. Overall, up to 90% of patients who are routinely on dialysis programs are vitamin D deficient, which is associated with increased arterial stiffness and calcification of vasculature, stroke, and left ventricular hypertrophy, and also increased mortality due to cardiovascular accidents [1, 12].

The purpose of this study was to review and assess children on regular dialysis programs and evaluate their serum vitamin D level and its relationship with calcium, phosphorus, serum PTH, and mortality in these patients.

2

Materials and Methods

The study was designed as a retrospective observational cross‐sectional study, and no new intervention was performed. All data from this study were collected retrospectively. All patients undergoing regular hemodialysis and peritoneal dialysis from 2018 to 2020 (53 patients) enrolled in the study. Patients with underlying non‐renal diseases such as hypertension, adrenal hyperplasia, coarctation of the aorta, and pheochromocytoma were excluded from the study. The variable of interest was age, gender, body mass index (BMI), drugs, type of dialysis, hypertension, calcium (Ca), phosphorus(P), and vitamin D level, PTH and CRP and urine residue, as well as diet compliance were evaluated every 1 to 3 months.

Arterial hypertension is defined by a sustained rise of blood pressure in 95% of recorded charts of BP. The χ 2 test was used to analyze the categorical variables. Statistical inferences related to associations between the serum 25(OH)D level and the outcomes were analyzed using the multivariate Cox proportional hazards regression analyses. p values more than 0.05 were considered statistically insignificant. All statistical analyses were done using statistical package for the social sciences (SPSS) Statistics 21 and analyzed to find any meaningful relations.

3

Results

This comprehensive study analyzed 53 pediatric dialysis patients, consisting of 28 boys and 25 girls. The demographic distribution revealed an average age of 8.21 months with a median of 9 years. The age categories were distinctly represented, with adolescents (over 12 years) comprising 8.2% of the population, children between 2 and 12 years representing the majority at 71.7%, and infants under 2 years accounting for 7.5% of the study population.

The assessment of residual kidney function revealed important distinctions among the patients. Thirty patients (56.7%) demonstrated no residual kidney function, while 23 patients (43.3%) maintained varying degrees of residual function. The metabolic status of the patients showed significant variations, with 32 patients (60%) presenting with metabolic acidosis, a single patient (1.8%) exhibiting metabolic alkalosis, and 20 patients (38.2%) maintaining normal acid‐base balance.

Laboratory analyses yielded crucial insights into vitamin D metabolism and related parameters. The mean serum vitamin D level was 23.51 ng/mL (median 22), displaying a positively skewed distribution that suggested a tendency toward deficiency in the study population. Parathyroid hormone levels demonstrated considerable variation, with a mean PTH level of 411.57, a median of 290, and a mode of 110, indicating diverse patterns of secondary hyperparathyroidism among the patients.

Statistical analyses revealed significant relationships between various parameters. Vitamin D levels showed a moderate positive correlation with calcium levels (correlation coefficient 0.6, p < 0.05) and duration of dialysis (correlation coefficient 0.52, p < 0.05). Through linear regression analysis, it was determined that vitamin D levels explained 12% of calcium variations (adjusted R² = 0.12). The duration of dialysis demonstrated a weak but significant correlation with calcium levels (correlation coefficient 0.2), with dialysis duration explaining 5% of serum calcium variations.

The mortality analysis revealed particularly striking findings. During the study period, 14 deaths were recorded, with statistical analysis demonstrating a highly significant association between vitamin D levels and mortality (p < 0.001). Patients with vitamin D levels below 15 ng/mL faced a hazard ratio of 3.2, indicating more than three times the mortality risk compared to those with higher vitamin D levels. The mortality pattern demonstrated clear stratification based on vitamin D levels, with severely deficient patients (< 15 ng/mL) experiencing a 64.7% mortality rate, moderately deficient patients (15 to 30 ng/mL) showing an 18.8% mortality rate, while remarkably, patients maintaining sufficient vitamin D levels (> 30 ng/mL) recorded no deaths during the study period (Figure 1).

The 24‐month survival analysis further reinforced these findings, demonstrating a clear gradient in survival rates. Patients with sufficient vitamin D levels maintained 100% survival, while those with severe deficiency showed only 35.3% survival. Notably, vitamin D levels below 15 ng/mL during summer months were particularly associated with increased mortality risk, establishing this threshold as a critical marker for clinical assessment.

Figure 1

Distribution of mortality by vitamin D level.

Figure image at the original source: open the original paper. This file is not included in this text import.

Comparative analysis between survivors and non‐survivors revealed no significant differences in several clinical parameters, including sex, dialysis frequency, weight, BMI, and CRP levels, suggesting that these factors may not be primary determinants of mortality in this population. Additionally, no significant correlations were identified between vitamin D levels and phosphorus, PTH, dialysis frequency, age, or weight (p > 0.05), suggesting independent regulatory mechanisms for these parameters.

The relationship between vitamin D levels and mortality remained robust and significant even after adjusting for potential confounding factors, establishing vitamin D status as an independent predictor of mortality risk. The identification of 15 ng/mL as a critical threshold for increased mortality risk provides an important clinical benchmark for risk assessment and intervention. These findings strongly suggest that vitamin D levels serve as a reliable prognostic indicator in pediatric dialysis patients, offering valuable guidance for clinical management and therapeutic intervention strategies.

Figure 1 shows the distribution of mortality by vitamin D levels. Table 1 demonstrates the demographic features in the study population, Table 2 shows the qualitative variables in the study population, and Table 3 presents the correlation of independent variables with vitamin D in dialysis in our patients.

Table 1

Demographic features in the study population.

Age (year)Weight (kg)Vitamin D (ng/mL)CaPPTHNumber of dialysis/weakYears on dialysis
Mean8.2126.6433.518.986.18411.572.743.17
Median926339629032
Mode5122294.3011031
Std. deviation4.31617.00918.4211.051.81354.370.442.73
Variance18.62289.31339.331.113.30125583.280.197.46
Range1473804.206.801403110
Minimum1446.803.302721
Maximum1577841110.101430311
Percentile
25512208.44.5128.521
50926339629032
75123643.59.87.4581.534

Abbreviations: Ca, Calcium; Ph, phosphorus; PTH, parathyroid hormone, if multiple modes exist then the smallest value is shown for mode.

John Wiley & Sons, Ltd.
Table 2

Qualitative variables in the study population.

FrequencyPercentValid percentCumulative percent
PUV + neurogenic bladder1630.230.230.2
Renal dysplasia815.115.145.3
RPGN/FSGS815.115.160.4
CHD, ARPKD, interstitial nephritis2139.639.6100
Renal residueYes2139.639.639.6
No3260.460.4100
Hemodialysis3056.656.656.6
Peritoneal dialysis2343.443.4100

Abbreviations: CHD, congenital heart disease; FSGS, focal segmental glomerulosclerosis; PUV, posterior urethral valves, RPGN, rapidly progressive glomerulonephritis.

John Wiley & Sons, Ltd.
Table 3

Correlation of independent variables with vitamin D in dialysis patients.

HTNMeanStd. deviation p value
HemoglobinYes10.99771.026270.05
No12.17501.76048
PTHYes164.10087.66540.991
No165.250139.2465
Vitamin DYes23.5168.52800.808
No41.33312.5628
Time of hemodialysis per dayYes2.8530.55240.155
No2.5880.5073
Number of dialysis per weekYes2.9410.55570.259
No3.1760.6359
John Wiley & Sons, Ltd.
4

Discussion

In this study of 53 pediatric dialysis patients, our most significant finding was the strong association between vitamin D levels and mortality, with patients having vitamin D levels below 15 ng/mL showing a hazard ratio of 3.2. This relationship was clearly demonstrated in mortality rates, where patients with severe vitamin D deficiency (< 15 ng/mL) experienced a 64.7% mortality rate, those with moderate deficiency (15 to 30 ng/mL) showed an 18.8% mortality rate, while remarkably, patients with sufficient vitamin D levels (> 30 ng/mL) recorded no deaths.

Our analyses also revealed significant positive correlations between vitamin D levels and both calcium levels and duration of dialysis, though no significant correlations were found with other clinical parameters.

Solarin and his colleagues conducted a retrospective investigation in 2019 that focused on the vitamin D status of children with moderate to severe chronic kidney disease. The research involved 46 children and adolescents below the age of 18, including 22 girls and 24 boys [16]. The findings indicated that while low vitamin D levels were linked to older age, there was no significant inverse correlation between vitamin D and PTH. In our study also, no significant association was observed between vitamin D and the age of children.

The Solarin study revealed that there was no correlation between gender and vitamin D levels, and those undergoing peritoneal dialysis exhibited lower vitamin D levels. Our study had similar results. In our study mortality rate had a significant relationship with peritoneal dialysis patients and low serum level of vitamin D. In a cross‐sectional study published in 2017 by Paulo Coccia and his colleagues, they studied 32 healthy control and 135 cases of CKD children and adolescents under 19 years old, they found Vitamin D deficiency is prevalent in 12.5% of controls and 25% of patients.

Patients with vitamin D deficiency had higher PTH levels and phosphate levels [22]. In our study, univariate analyses showed vitamin D level is directly associated with calcium and phosphorus (p > 0.05), but there was no significant association with age, sex, weight, underlying disease, urinary residue, and the number of dialyses per week (p < 0.05). In a case‐control study published by Doaa M. Youssef and her colleagues on 27 ESRD cases and 20 controls in 2010, they found no significant relationship between age, disease duration, dialysis duration, and PTH between the subgroups of ESRD [23].

Similar to our findings, where calcitriol supplementation in dialysis patients showed no significant effect on mortality and spinal fracture rates, only one study has demonstrated improved survival rates with calcitriol treatment in hemodialysis patients [17]. Another cross‐sectional study by Debora R. Stein and her colleagues on 100 CKD patients, including 60 boys and 40 girls in 2012 found a high prevalence of hyperparathyroidism in the early stages of disease and a significant relationship between vitamin D and PTH.

Also, this study showed that improving vitamin D levels is effective in controlling of hyperparathyroidism [24]. Unlike our study, no significant relationship between vitamin D and PTH was observed. Based on Spearman’s correlation analysis there was a weak relationship between calcium and years of dialysis with vitamin D (p < 0.05). In cross‐sectional study done by H. Taskapan and his colleagues in 2006, on 273 children undergoing peritoneal dialysis (123 girls and 150 boys) they did not find any significant relation between the level of 25(OH)D3 and the gender of the patients [25].

Also, they report an inverse correlation between the level of 25(OH)D3, age and the presence of diabetes, and a direct correlation of calcium and 1,25(OH)2D3 was reported. In our study, we find a significant correlation between serum vitamin D and calcium, but there is no significant relation with the gender of the patients. Maryanne Machado da Silva Canhos and colleagues showed annual average vitamin D levels < 23.1 ng/mL were associated with higher all‐cause mortality [26]. Regardless of the confounding variables evaluated, in our study serum vitamin D less than 15 ng/ml was associated with higher mortality rate although some studies suggest serum level of 25(OH)D below 23.6 ng/mL in summer is associated with higher mortality rates [26].

5

Implication for Practice

According to our study, managing vitamin D supplementation in children on dialysis can follow standard WHO (KDIGO) guidelines, similar to the approach used for healthy children, regardless of their serum vitamin D levels. We observed that children with CKD who maintain residual kidney function typically demonstrate more favorable vitamin D levels, which can be attributed to their remaining functional renal tissue continuing to participate in vitamin D metabolism. For optimal care of children on regular dialysis programs, consistent monitoring of vitamin D, calcium, phosphorus, and PTH levels is essential.

This vigilant monitoring approach plays a crucial role in preventing renal osteodystrophy, reducing the risk of bone fractures, avoiding cardiovascular complications, and ultimately lowering both morbidity and mortality rates in this vulnerable population.

Author Contributions

Sima Shamshiri Khamene: investigation, methodology, software, and formal analysis. Izat Mohammad Khawajah: investigation, methodology, software, and formal analysis. Mastaneh Moghtaderi: conceptualization, investigation, writing: original draft, methodology, validation, visualization, writing: review and editing, software, formal analysis, project administration, data curation, supervision, and resources.

Funding

The authors received no specific funding for this work.

Ethics Statement

The method was approved in compliance with scientific and ethical standards. All procedures were performed in line with the relevant guidelines and regulations. The Medical Ethics Committee of Tehran University of Medical Sciences approved this study.

Informed Consent

As our patients were under 16 years old, all the parents or guardians were informed and signed the informed consent form.

Conflicts of Interest

The authors declare no conflicts of interest.

Transparency Statement

The corresponding author, Mastaneh Moghtaderi, affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.

Data Availability Statement

The data supporting this study’s findings are available on request from the corresponding author. The data sets created during the current study are not publicly accessible due to the possibility of compromising individuals’ privacy.

References

1 E. Habas , Sr. , M. Eledrisi , F. Khan , and A. Y. Elzouki , “Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management ,” Cureus 13 , no. 7 (July 2021 ): 16388. 10.7759/cureus.16388 PMC8362860 34408941
2 D. Bikle and S. Christakos , “New Aspects of Vitamin D Metabolism and Action: Addressing the Skin as Source and Target ,” Nature Reviews Endocrinology 16 , no. 4 (April 2020 ): 234Not reported252 . 10.1038/s41574-019-0312-5 32029884
3 S. M. Jeon and E. A. Shin , “Exploring Vitamin D Metabolism and Function in Cancer ,” Experimental & Molecular Medicine 50 , no. 4 (April 2018 ): 1Not reported14 . 10.1038/s12276-018-0038-9 PMC5938036 29657326
4 A. Giustina , R. A. Adler , N. Binkley , et al., “Controversies in Vitamin D: Summary Statement From an International Conference ,” Journal of Clinical Endocrinology and Metabolism 104 , no. 2 (February 2019 ): 234Not reported240 . 30383226 10.1210/jc.2018-01414
5 M. Herrmann , C. J. L. Farrell , I. Pusceddu , N. Fabregat‐Cabello , and E. Cavalier , “Assessment of Vitamin D Status: A Changing Landscape ,” Clinical Chemistry and Laboratory Medicine (CCLM) 55 , no. 1 (January 2017 ): 3Not reported26 . 27362963 10.1515/cclm-2016-0264
6 D. Goltzman , “Functions of Vitamin D in Bone ,” Histochemistry and Cell Biology 149 , no. 4 (April 2018 ): 305Not reported312 . 29435763 10.1007/s00418-018-1648-y
7 L. Hadjadj , “Effect of Hyperandrogenism and Vitamin D Deficiency on Metabolic Parameters and Coronary Artery Function in Female Rats” (PhD diss.) .
8 B. Han , F.‐X. Zhu , H.‐F. Yu , S. Liu , and J. L. Zhou , “Low Serum Levels of Vitamin D Are Associated With Anxiety in Children and Adolescents With Dialysis ,” Scientific Reports 8 , no. 1 (2018 ): 5956 . 29654252 10.1038/s41598-018-24451-7 PMC5899084
9 K. A. Herrick , R. J. Storandt , J. Afful , et al., “Vitamin D Status in the United States, 2011 to 2014 ,” American Journal of Clinical Nutrition 110 , no. 1 (July 2019 ): 150Not reported157 . 31076739 10.1093/ajcn/nqz037 PMC7263437
10 G. Jean , J. Souberbielle , and C. Chazot , “Vitamin D in Chronic Kidney Disease and Dialysis Patients ,” Nutrients 9 , no. 4 (March 2017 ): 328 . 28346348 10.3390/nu9040328 PMC5409667
11 N. V. Grygorieva , T. Y. Solonenko , A. S. Musiienko , et al., “Vitamin D Deficiency in Ukraine: Current Evidence ,” BMC Nutrition 9 (November 2023 ): 49 , 10.1186/s40795-023-00706-z . 36918995 PMC10014139
12 N. Kamath . and A. A. Iyengar , “Chronic Kidney Disease (CKD): An Observational Study of Etiology, Severity and Burden of Comorbidities ,” Indian Journal of Pediatrics 84 (November 2017 ): 822Not reported825 . 28711960 10.1007/s12098-017-2413-2
13 F. Caravaca‐Fontán , B. Gonzales‐Candia , E. Luna , and F. Caravaca , “Relative Importance of the Determinants of Serum Levels of 25‐Hydroxy Vitamin D in Patients With Chronic Kidney Disease ,” Nefrología (English Edition) 36 , no. 5 (September 2016 ): 510Not reported516 . 10.1016/j.nefro.2016.01.017 27378232
14 K. Amrein , M. Scherkl , M. Hoffmann , et al., “Vitamin D Deficiency 2.0: An Update on the Current Status Worldwide ,” European Journal of Clinical Nutrition 74 , no. 11 (November 2020 ): 1498Not reported5113 . 31959942 10.1038/s41430-020-0558-y PMC7091696
15 F. Zappulo , M. Cappuccilli , A. Cingolani , et al., “Vitamin D and the Kidney: Two Players, One Console ,” International Journal of Molecular Sciences 23 , no. 16 (August 2022 ): 9135 . 36012412 10.3390/ijms23169135 PMC9409427
16 A. Solarin , P. Nourse , and P. Gajjar , “Vitamin D Status of Children With Moderate to Severe Chronic Kidney Disease at a Tertiary Pediatric Center in Cape Town ,” Saudi Journal of Kidney Diseases and Transplantation 30 , no. 4 (July 2019 ): 781Not reported794 . 31464234 10.4103/1319-2442.265453
17 B. Satirapoj , P. Limwannata , A. Chaiprasert , O. Supasyndh , and P. Choovichian , “Vitamin D Insufficiency and Deficiency With Stages of Chronic Kidney Disease in an Asian Population ,” BMC Nephrology 14 (December 2013 ): 206 . 24083392 10.1186/1471-2369-14-206 PMC3850679
18 B. Han , F. X. Zhu , H. F. Yu , S. Liu , and J. L. Zhou , “Low Serum Levels of Vitamin D Are Associated With Anxiety in Children and Adolescents With Dialysis ,” Scientific Reports 8 , no. 1 (April 2018 ): 5956 . 29654252 10.1038/s41598-018-24451-7 PMC5899084
19 N. J. A. Webb , G. Lerner , B. A. Warady , et al., “Efficacy and Safety of Paricalcitol in Children With Stages 3 to 5 Chronic Kidney Disease ,” Pediatric Nephrology 32 (July 2017 ): 1221Not reported1232 . 28332096 10.1007/s00467-017-3579-6 PMC5440538
20 J. S. Yokoyama , M. Matsuda‐Abedini , M. R. Denburg , et al., “Association Between Chronic Kidney Disease: Mineral Bone Disease (CKD‐MBD) and Cognition in Children: Chronic Kidney Disease in Children (CKID) Study ,” Kidney Medicine 2 , no. 4 (July 2020 ): 398Not reported406 . 32775979 10.1016/j.xkme.2020.03.005 PMC7406846
21 R. Shroff , M. Wan , E. V. Nagler , et al., “Clinical Practice Recommendations for Native Vitamin D Therapy in Children With Chronic Kidney Disease Stages 2 to 5 and on Dialysis ,” Nephrology Dialysis Transplantation 32 , no. 7 (July 2017 ): 1098Not reported1113 . 10.1093/ndt/gfx065 PMC5837199 28873969
22 P. Coccia , J. Blazquez , M. Contreras , et al., “High Prevalence of Vitamin D Deficiency Among Children With Chronic Kidney Disease and Kidney Transplant ,” Archivos Argentinos de Pediatria 115 , no. 3 (June 2017 ): 220Not reported226 . 28504486 10.5546/aap.2017.eng.220
23 D. M. Youssef , A. S. Elshal , and A. A. Abo Elazem , “Assessment of Immune Status in Relation to Vitamin D Levels in Children on Regular Hemodialysis ,” Saudi Journal of Kidney Diseases and Transplantation 23 , no. 2 (March 2012 ): 267Not reported273 . 22382217
24 D. R. Stein , H. A. Feldman , and C. M. Gordon , “Vitamin D Status in Children With Chronic Kidney Disease ,” Pediatric Nephrology 27 (August 2012 ): 1341Not reported1350 . 22453735 10.1007/s00467-012-2143-7 PMC3749087
25 H. Taskapan , F. F. Ersoy , P. S. Passadakis , et al., “Severe Vitamin D Deficiency in Chronic Renal Failure Patients on Peritoneal Dialysis ,” Clinical Nephrology 66 , no. 4 (October 2006 ): 247Not reported255 . 17063991 10.5414/cnp66247
26 M. M. da Silva Canhos , R. C. De Oliveira , L. G. Modelli de Andrade , J. C. T. Caramori , P. Barretti , and L. C. Martin , “Association Between Vitamin D Levels and Mortality in Hemodialysis Patients: A Cohort Study ,” Renal Failure 42 , no. 1 (January 2020 ): 225Not reported233 . 32126885 10.1080/0886022X.2020.1735415 PMC7067165
Publication and source details

Original title: Association Between Serum Vitamin D Levels and Mortality in Children Receiving Chronic Dialysis: A Retrospective Cohort Study

Sima Shamshiri Khamene; Izat Mohammad Khawajah; Mastaneh Moghtaderi

Health Science Reports · 2026

* Correspondence: Mastaneh Moghtaderi (drmoghtaderi@gmail.com)
© 2026 The Author(s). Health Science Reports published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:10:47.212012+00:00

DOI: 10.1002/hsr2.71804 · PMC12865220